Trioxsalen
Back to searchMolecule Structure
Scientific Name
Trioxsalen
Description of the Drug
Trioxsalen is a psoralen derivative that has been used in combination with UV light to treat vitiligo, but has been discontinued by its manufacturer.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB04571
http://www.drugbank.ca/drugs/DB04571
Brand Name(s)
Trisoralen
Company Owner(s)
Valeant Pharmaceuticals International
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
DNA | NUCLEIC-ACID | INHIBITOR | CHEMBL2311221 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL1252 |
Human Metabolome Database | HMDB0015575 |
DrugBank | DB04571 |
PubChem: Thomson Pharma | 14773742 |
PubChem | 5585 |
Mcule | MCULE-5301264270 |
NMRShiftDB | 70070422 |
LINCS | LSM-3223 |
Nikkaji | J3.411H |
BindingDB | 50240033 |
EPA CompTox Dashboard | DTXSID3023716 |
DrugCentral | 2759 |
Brenda | 209567 |
ChemicalBook | CB1363250 |
rxnorm | TRIOXSALEN |
KEGG Ligand | C09314 |
ChEBI | 28329 |
ZINC | ZINC000000002226 |